Trials / Unknown
UnknownNCT00343668
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
A Phase II Study of S-1 and Irinotecan Combination Chemotherapy in Patients With Advanced Gastric Cancer as a First-Line Therapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Korean Cancer Study Group · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this phase II trial is to evaluate the response rate of combination chemotherapy with S-1 and Irinotecan in patients with advanced gastric cancer as a first-line therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1, irinotecan | S-1, 40 mg/m2 PO twice daily, days 1-14 irinotecan, 150 mg/m2 IV, day 1 |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-03-01
- Completion
- 2008-07-01
- First posted
- 2006-06-23
- Last updated
- 2010-05-26
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00343668. Inclusion in this directory is not an endorsement.